|
| 1 |
RSK2 and its binding partners in cell proliferation, transformation and cancer development
Cho, Yong-Yeon;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.291-303,
|
|
| 2 |
Cinnamomulactone, a new butyrolactone from the twigs of Cinnamomum cassia and its inhibitory activity of matrix metalloproteinases
Kim, Geum Jin;Lee, Jong Yeong;Choi, Hyun Gyu;Kim, So Young;Kim, Eonmi;Shim, Sang Hee;Nam, Joo-Won;Kim, Sang-Hyun;Choi, Hyukjae;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.304-310,
|
|
| 3 |
A new saponin from Acanthopanax koreanum with anti-inflammatory activity
Le, Duc Dat;Nguyen, Phuong Thao;Bui, Thi Thuy Luyen;Bui, Huu Tai;Woo, Mi Hee;Manzoor, Zahid;Ali, Irshad;Koh, Young Sang;Kim, Young Ho;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.311-317,
|
|
| 4 |
Oleanane triterpenoids from Akebiae Caulis exhibit inhibitory effects on Aβ42 induced fibrillogenesis
Chowdhury, Md. Anisuzzaman;Ko, Hae Ju;Lee, Hwan;Haque, Md. Aminul;Park, Il-Seon;Lee, Dong-Sung;Woo, Eun-Rhan;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.318-327,
|
|
| 5 |
Anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungal strain Penicillium sp. SF-5629
Nguyen, Thi Thanh Ngan;Tran, Hong Quang;Kim, Kwan-Woo;Kim, Hye Jin;Sohn, Jae Hak;Kang, Dae Gill;Lee, Ho Sub;Kim, Youn-Chul;Oh, Hyuncheol;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.328-337,
|
|
| 6 |
Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L.
Kuk, Eun Bi;Jo, A. Ra;Oh, Seo In;Sohn, Hee Sook;Seong, Su Hui;Roy, Anupom;Choi, Jae Sue;Jung, Hyun Ah;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.338-349,
|
|
| 7 |
Liquid chromatographic enantiomer separation of 1-naphthylamides of chiral acids using several amylose- and cellulose-derived chiral stationary phases
Islam, Md. Fokhrul;Adhikari, Suraj;Paik, Man-Jeong;Lee, Wonjae;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.350-355,
|
|
| 8 |
Chitosan-ceramide coating on gold nanorod to improve its physiological stability and reduce the lipid surface-related toxicity
Battogtokh, Gantumur;Gotov, Oyuntuya;Ko, Young Tag;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.356-363,
|
|
| 9 |
Determination of urazamide in pharmaceutical preparation with room temperature ionic liquid
Seo, Narae;Lee, Yoo Rim;Park, Hyun Sun;Truong, Quoc-Ky;Lee, Jae-Yong;Chung, Hyun Kyu;Choi, Yusung;Kim, Byeonghee;Han, Sang Beom;Kim, Kyeong Ho;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.364-372,
|
|
| 10 |
Determination of rabeprazole enantiomers in commercial tablets using immobilized cellulose-based stationary phase
Kim, Miri;Yu, Su Kyung;Truong, Quoc-Ky;Mai, Xuan-Lan;Chung, Hyun Kyu;Kang, Jong-Seong;Kim, Kyeong Ho;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.373-381,
|
|
| 11 |
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite
Kim, Se-Hyung;Kim, Do-Hoon;Byeon, Ji-Yeong;Kim, Young-Hoon;Kim, Dong-Hyun;Lim, Hye-Jin;Lee, Choong-Min;Whang, Sang Sup;Choi, Chang-Ik;Bae, Jung-Woo;Lee, Yun Jeong;Jang, Choon-Gon;Lee, Seok-Yong;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.382-390,
|
|
| 12 |
Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin
Park, Jeong-hyeon;Choi, Bo-hyun;Ku, Sae-Kwang;Kim, Dong-hyun;Jung, Kyeong-Ah;Oh, Euichaul;Kwak, Mi-Kyoung;
/
The Pharmaceutical Society of Korea
, v.40, no.3, pp.391-402,
|
|